About this journal

Aims and scope

Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of human genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.

In particular, emphasis will be given to:

  • Genomic and proteomic profiling
  • Genetics and drug metabolism
  • Genetic variability in drug toxicity and efficacy
  • Genetic-based vaccine development
  • Targeted drug identification, discovery and delivery
  • Optimizing drug selection and dosage based on patient's genetic profile
  • Drug related morbidity and mortality intervention
  • Advanced disease screening and targeted therapeutic intervention
  • Practical and organizational challenges in the development and implementation of personalized medicine programs
  • Patient satisfaction and preference
  • Health economic evaluations of personalized medicine

When considering submission of a paper utilizing publicly-available data (e.g. GWAS/TCGA/GEO etc.), authors should ensure that such studies add significantly to the body of knowledge about a specific disease or relevant phenotype and that they are validated using the authors own data through replication in an independent sample set and functional follow-up. Bioinformatics studies should also conform to these criteria. Animal-only studies will not be considered.

The journal welcomes submitted papers covering original research, clinical studies, reviews and evaluations, guidelines, policy papers, expert opinion and commentary, case reports and extended reports.

Pharmacogenomics and Personalized Medicine will no longer consider meta-analyses for publication.

Journal metrics

Usage

  • 73K annual downloads/views

Citation metrics

  • 1.8 (2023) Impact Factor
  • 1.9 (2023) 5 year IF
  • 3.3 (2023) CiteScore (Scopus)
  • 0.544 (2023) SNIP
  • 0.508 (2023) SJR

Editorial board

Editor-in-Chief

Martin H Bluth, Dr, Pathology, Maimonides Medical Center, Chief of Blood Transfusion Medicine and Donor Services, Assistant Director of Clinical Laboratories and Director of Translational Research for the Department of Pathology at Maimonides Medical Center, Professor of Pathology at Wayne State University School of Medicine and Global Medical Director for Kids Kicking Cancer, United States

Editorial Board

Hiltrud Brauch, Professor, Institute of Clinical Pharmacology, Stuttgart University, Germany

Carolyn Compton, Professor, Life Sciences, Arizona State University, United States

Vicki Ellingrod, Professor, Clinical Social and Administrative Sciences, College of Pharmacy and Medicine, University of Michigan, MI, United States

Takahisa Furuta, Professor, Furuta Clinic of Medicine, Japan

Jing Li, Professor, Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, United States

Qing Ma, Professor, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, United States

Anke-Hilse Maitland-van der Zee, Professor, Precision Medicine in Respiratory Diseases, Faculty of Medicine, University of Amsterdam, Netherlands

Gene Morse, Professor, Pharmacy, University at Buffalo, United States

Wolfgang Sadee, Dr.rer.nat, Professor Emeritus, Cancer Biology and Genetics, The Ohio State University and Professor Emeritus, Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, USA

Andrew Somogyi, Professor, Pharmacology, University of Adelaide, Australia

Michael A. Tainsky, Professor, Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, United States

Abstracting and indexing

Pharmacogenomics and Personalized Medicine is indexed/tracked/covered by the following services:

Biological Abstracts

BIOSIS Previews (Clarivate Analytics)

Directory of Open Access Journals (DOAJ)

EMBASE (Elsevier)

Journal Citation Reports/Science Edition

Pubmed (NLM)

PubMed Central Selective Deposit Medicine & Health (NLM)

Science Citation Index Expanded (Clarivate Analytics)

Scopus (Elsevier)

Open access

Pharmacogenomics and Personalized Medicine is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.

Use our APC finder to calculate your article publishing charge

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors